PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVAH vs. HCAT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AVAH and HCAT is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

AVAH vs. HCAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-7.57%
-21.33%
AVAH
HCAT

Key characteristics

Sharpe Ratio

AVAH:

1.32

HCAT:

-0.65

Sortino Ratio

AVAH:

2.26

HCAT:

-0.83

Omega Ratio

AVAH:

1.27

HCAT:

0.90

Calmar Ratio

AVAH:

1.22

HCAT:

-0.49

Martin Ratio

AVAH:

8.03

HCAT:

-1.54

Ulcer Index

AVAH:

12.61%

HCAT:

28.95%

Daily Std Dev

AVAH:

76.63%

HCAT:

69.19%

Max Drawdown

AVAH:

-94.76%

HCAT:

-90.79%

Current Drawdown

AVAH:

-61.13%

HCAT:

-90.54%

Fundamentals

Market Cap

AVAH:

$968.06M

HCAT:

$337.70M

EPS

AVAH:

-$0.35

HCAT:

-$1.34

Total Revenue (TTM)

AVAH:

$1.50B

HCAT:

$226.98M

Gross Profit (TTM)

AVAH:

$458.08M

HCAT:

$85.54M

EBITDA (TTM)

AVAH:

$105.60M

HCAT:

-$15.03M

Returns By Period

In the year-to-date period, AVAH achieves a 9.63% return, which is significantly higher than HCAT's -21.50% return.


AVAH

YTD

9.63%

1M

7.74%

6M

-7.14%

1Y

119.74%

5Y*

N/A

10Y*

N/A

HCAT

YTD

-21.50%

1M

1.09%

6M

-22.38%

1Y

-42.84%

5Y*

-28.79%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AVAH vs. HCAT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVAH
The Risk-Adjusted Performance Rank of AVAH is 8383
Overall Rank
The Sharpe Ratio Rank of AVAH is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of AVAH is 8383
Sortino Ratio Rank
The Omega Ratio Rank of AVAH is 7979
Omega Ratio Rank
The Calmar Ratio Rank of AVAH is 8282
Calmar Ratio Rank
The Martin Ratio Rank of AVAH is 8888
Martin Ratio Rank

HCAT
The Risk-Adjusted Performance Rank of HCAT is 1313
Overall Rank
The Sharpe Ratio Rank of HCAT is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of HCAT is 1313
Sortino Ratio Rank
The Omega Ratio Rank of HCAT is 1515
Omega Ratio Rank
The Calmar Ratio Rank of HCAT is 1717
Calmar Ratio Rank
The Martin Ratio Rank of HCAT is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AVAH vs. HCAT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AVAH, currently valued at 1.32, compared to the broader market-2.000.002.001.32-0.65
The chart of Sortino ratio for AVAH, currently valued at 2.26, compared to the broader market-4.00-2.000.002.004.006.002.26-0.83
The chart of Omega ratio for AVAH, currently valued at 1.27, compared to the broader market0.501.001.502.001.270.90
The chart of Calmar ratio for AVAH, currently valued at 1.22, compared to the broader market0.002.004.006.001.22-0.49
The chart of Martin ratio for AVAH, currently valued at 8.03, compared to the broader market0.0010.0020.0030.008.03-1.54
AVAH
HCAT

The current AVAH Sharpe Ratio is 1.32, which is higher than the HCAT Sharpe Ratio of -0.65. The chart below compares the historical Sharpe Ratios of AVAH and HCAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
1.32
-0.65
AVAH
HCAT

Dividends

AVAH vs. HCAT - Dividend Comparison

Neither AVAH nor HCAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AVAH vs. HCAT - Drawdown Comparison

The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum HCAT drawdown of -90.79%. Use the drawdown chart below to compare losses from any high point for AVAH and HCAT. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%SeptemberOctoberNovemberDecember2025February
-61.13%
-90.54%
AVAH
HCAT

Volatility

AVAH vs. HCAT - Volatility Comparison

Aveanna Healthcare Holdings Inc. (AVAH) has a higher volatility of 15.90% compared to Health Catalyst, Inc. (HCAT) at 14.01%. This indicates that AVAH's price experiences larger fluctuations and is considered to be riskier than HCAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
15.90%
14.01%
AVAH
HCAT

Financials

AVAH vs. HCAT - Financials Comparison

This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Health Catalyst, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab